Cargando…
Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution'
An urgent requirement exists for new prognostic and predictive assays in breast cancer. Despite the development of high-throughput technologies such as DNA microarrays, it would now appear that immunohistochemistry (IHC) may play an increasingly important role in the clinical management of breast ca...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374964/ https://www.ncbi.nlm.nih.gov/pubmed/18331621 http://dx.doi.org/10.1186/bcr1854 |